Screaming Buys: 2 Value Stocks That Increased Their Dividends

This pair of value stocks are screaming buys following their impressive quarterly results and dividend hikes.

| More on:
sale discount best price

Image source: Getty Images

This year has been tremendously upsetting for stock investors because market rallies are few and far between. Canada’s primary stock exchange has been shaky due to geopolitical tensions, supply chain disruptions, and inflationary pressures. Despite closing above 20,000 for the first time in more than two months on August 12, 2022, the TSX remains vulnerable.

However, during times of uncertainty, mediocre stocks take the back seat while quality stocks emerge. If you’re after value-for-money, Exchange Income Corporation (TSX:EIF), or EIC, and Medical Facilities (TSX:DR) are screaming buys today. Both companies reported impressive financial results in Q2 2022 and announced dividend increases.

Solid revenue and earnings growth

EIC investors are more than satisfied with their stock’s 19.8% positive return year to date amid the uncertainties. Its CEO, Mike Pyle, said, “The work you do in the past defines your future. Throughout the pandemic EIC stayed true to its business model, maintaining a strong balance sheet, investing in its companies, acquiring companies that meet our criteria and empowering our people.”

The $2 billion company has two core business segments, namely Aerospace & Aviation and Manufacturing. In Q2 2022, EIC achieved several milestones. The $529 million revenue and $30 million in net earnings were both record highs in the quarter, up 64% and 82%, respectively, versus Q2 2021.

Also, during the quarter, management increased its dividend (second consecutive quarter) by $0.12 per annum to $2.52. If you invest today ($48.93 per share), the dividend yield is a hefty 4.9%.

A cut above the rest  

Medical Facilities is a cut above the rest, considering that health care (-47.9%) is the worst-performing sector as of Friday last week. This health care stock is actually outperforming the broader market, up 11.5% versus a decline of -4.9% for the TSX year to date. Also, at $10.25 per share, the dividend yield is a decent 3.14%.

The $331.7 million company operates in the United States and owns a diverse portfolio of high-rated, high-quality surgical facilities. Currently, its controlling interests are in four specialty surgical hospitals and one ambulatory surgery centre. Moreover, the ownership stakes in five more ambulatory surgery centres are in partnership with NueHealth LLC.

Medical Facilities has a unique setup because the company partners with physicians who have a say in operations. In the first half of 2022, total revenue and other income increased by 4.5% to $196.3 million versus the same period in 2021. While net income in FH 2022 declined 4.7% year over year, net income in Q2 2022 versus Q2 2021 jumped 87.6% to US$22.2 million.

Robert O. Horrar, President and CEO of Medical Facilities, said, “Our surgical case volumes continued to improve in the quarter, particularly in the month of June, when volumes exceeded June 2021 volumes by 8.1% and June 2019, which was before the pandemic, by 8.9%.”

However, higher labor costs and other operating expenses had an impact on profitability. Still, Horrar assures that cash flow and the balance sheet remain strong. During the quarter, management raised its dividend by 3.7% (annualized yield).

Undervalued

Dividend-paying value stocks Exchange Income and Medical Facilities deserve serious consideration. Despite the outperformance, the share prices aren’t commensurate with their intrinsic or real values.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Christopher Liew has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned.

More on Dividend Stocks

dividends grow over time
Dividend Stocks

Got $5,000 to Invest? 3 Insurance Stocks to Buy and Hold Forever

These three insurance stocks are the perfect options for those wanting security, stability, and dividends.

Read more »

calculate and analyze stock
Dividend Stocks

Outlook for Restaurant Brands International Stock in 2025

QSR stock has had a turbulent few years, but investors may not want to count out the stock just yet.

Read more »

ways to boost income
Dividend Stocks

Prediction: 10 Years From Now, You’ll Be Glad You Bought These Winners

Investing in these two under-the-radar stocks right now could pay off really well over the next 10 years or beyond.

Read more »

3 colorful arrows racing straight up on a black background.
Dividend Stocks

3 TSX Stocks Soaring Higher With No Signs of Slowing

These TSX stocks have already had a strong year, but the three companies look like they could just be getting…

Read more »

A worker gives a business presentation.
Dividend Stocks

How to Use Your TFSA to Earn $300 in Monthly Tax-Free Passive Income

Do you want some monthly tax-free passive income? Here are three top picks that can give you $300 or more…

Read more »

Confused person shrugging
Dividend Stocks

BCE Stock: Undervalued or Just a Value Trap?

Down over 50% from all-time highs, BCE stock trades at a cheap multiple in 2025. But is the TSX dividend…

Read more »

An investor uses a tablet
Dividend Stocks

5 Canadian Dividend Stocks Everyone Should Own

These dividend stocks will consistently pay and increase their dividends, making them attractive investment to generate passive income.

Read more »

grow money, wealth build
Dividend Stocks

Got $7,000? 5 Blue-Chip Stocks to Buy and Hold Forever

These blue-chip stocks have solid fundamentals, growing earnings bases, and the ability to deliver steady growth and income.

Read more »